Cimit

2.3K posts

Cimit banner
Cimit

Cimit

@Cimit

Cimit helps leaders tackle complex health problems by providing the expertise needed to rapidly advance groundbreaking solutions.

Boston, MA เข้าร่วม Ocak 2009
454 กำลังติดตาม1.2K ผู้ติดตาม
Cimit
Cimit@Cimit·
Are you an early-stage #neurotech innovator? NTH’s Early Entrepreneurs Program is now accepting applications. EEP is designed to help researchers, clinicians, and founders move early #neurotechnology ideas toward commercialization. Apply by Dec 31: lnkd.in/eUwcmtKY
Cimit tweet media
English
0
0
0
23
Cimit
Cimit@Cimit·
DEADLINE APPROACHING: Do you have a groundbreaking point-of-care medical technology? This is your last chance to apply for an innovation award from the POCTRN program! 📷 Deadline: June 6, 2025 📷 Awards up to $150K 📷 12-month in-kind support conta.cc/44x6b6y
Cimit tweet media
English
0
1
0
303
Cimit
Cimit@Cimit·
Researchers from Stanford, UT Austin and TU Delft have their eyes set on restoring vision and hope. Aided by the NIH Blueprint MedTech program they are developing an artificial retina to treat blindness. conta.cc/3YUkDlo #neurotechnology #neurotech #MedTech
Cimit tweet media
English
0
0
0
84
Cimit
Cimit@Cimit·
A game-changing hep C virus rapid test has received @US_FDA approval for the U.S. market. The test – validated in part by @NIH RADx Tech w/ @CDCgov gives results in an hour at the #pointofcare so treatment can start asap. We're honored to have helped! fda.gov/news-events/pr…
English
0
0
1
150
Cimit รีทวีตแล้ว
NIBIB
NIBIB@NIBIBgov·
A game-changing hep C virus rapid test has received @US_FDA approval for the U.S. market. The test – validated in part by the @NIH RADx Tech program w/ @CDCgov gives results in an hour at the point of care so treatment can start right away. Learn more: fda.gov/news-events/pr…
English
2
10
22
19.5K
Cimit
Cimit@Cimit·
The #RADxTech Home Test to Treat program is now offering at-home tests for #COVID and #Flu! Free at-home testing, telehealth & treatment is available to those eligible. Visit test2treat.org or call 1-800-682-2829 to register.
Cimit tweet media
English
0
0
0
107